Aging clock analysis identifies key genes in opioid dependence

Opioid dependence is a chronic and relapsing condition associated with substantial health and societal burdens. Chronic opioid exposure can affect neuronal signaling, immune function, metabolism, and other biological processes, yet the molecular mechanisms underlying dependence remain incompletely understood. Increasing evidence also suggests that substance use disorders may be associated with molecular changes related to aging, raising questions about how chronic opioid exposure interacts with age-dependent processes in the brain.

A major component of the study involved developing a transcriptomic aging clock-an algorithm that estimates age from patterns of gene expression. The researchers trained an elastic net regression model exclusively on the 21 healthy control samples and then applied it across the dataset. The model showed moderate predictive performance, with a correlation of r = 0.686 between predicted and chronological age and a mean absolute error of 5.16 years.

The analysis revealed striking differences in age-prediction residuals. Younger individuals with opioid dependence had positive residuals, averaging 14.6 years, whereas older individuals had negative residuals, averaging −7.2 years. However, the researchers caution that these findings should not be interpreted simply as evidence that opioid dependence accelerates aging in younger people while reversing it in older individuals. Instead, the pattern may reflect nonlinear transcriptomic remodeling associated with opioid dependence, as well as differences in brain-cell composition and limitations in age matching and model calibration.

"Together, these findings suggest that opioid dependence is associated with age-dependent and nonlinear transcriptomic remodeling rather than uniform effects on biological aging trajectories."

Together, the transcriptomic and genetic analyses point toward an interconnected biological picture involving neuroinflammation, neuronal signaling, synaptic function, and age-related molecular processes. The convergence of inflammatory hub genes and genes associated with age-related transcriptional states also raises the possibility that neuroimmune dysregulation may represent an important biological connection between opioid dependence and molecular changes associated with brain aging.

The researchers emphasize several important limitations. The transcriptomic dataset was relatively small, the healthy control group was older on average than the younger opioid-dependence group, and the brain RNA-seq data came from bulk tissue rather than individual cell types. Potential confounding factors-including opioid exposure history, polysubstance use, smoking, medications, medical and psychiatric conditions, and postmortem interval-were also not uniformly available. In addition, the aging clock was modeled using chronological age rather than independently measured biological age.

Overall, the findings suggest that opioid dependence is associated with distinct immune, neuronal, genetic, and age-related transcriptional signatures. Rather than demonstrating a simple acceleration of biological aging, the study points to a more complex pattern in which opioid dependence may alter age-associated gene expression differently across the lifespan. Future studies using larger and better age-matched cohorts, single-cell or spatial transcriptomics, and more robust measures of biological age could help determine how these molecular changes contribute to addiction susceptibility, progression, and long-term neurological consequences.

Source:

Aging-US

Journal reference: